5 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Korro Bio, Inc. | 4 |
| Korro Bio, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19189150 | Untitled | Korro Bio, Inc. | TRAN, CHRISTINA L | 1637 | Non-Final OA | |
| 17985978 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF RETINOCHISIN 1 (RS1) | Korro Bio, Inc. | WHITEMAN, BRIAN A | 1636 | Non-Final OA | Nov 14, 2022 |
| 17985963 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF GAP JUNCTION PROTEIN BETA 2 (GJB2) | Korro Bio, Inc. | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Nov 14, 2022 |
| 17986014 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) | Korro Bio, Inc. | SHIN, DANA H | 1635 | Non-Final OA | Nov 14, 2022 |
| 17986020 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF OTOFERLIN (OTOF) | Korro Bio, Inc. | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Non-Final OA | Nov 14, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial